1. Home
  2. UGRO vs PRFX Comparison

UGRO vs PRFX Comparison

Compare UGRO & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

SELL

Current Price

$3.79

Market Cap

2.5M

ML Signal

SELL

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$2.96

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
PRFX
Founded
2014
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UGRO
PRFX
Price
$3.79
$2.96
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$75.00
N/A
AVG Volume (30 Days)
48.3K
1.3M
Earning Date
02-10-2026
10-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$23,942,741.00
N/A
Revenue This Year
$98.41
N/A
Revenue Next Year
$23.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$2.57
52 Week High
$21.50
$27.35

Technical Indicators

Market Signals
Indicator
UGRO
PRFX
Relative Strength Index (RSI) 87.29 76.82
Support Level $0.11 $2.57
Resistance Level $4.50 $3.71
Average True Range (ATR) 0.21 0.28
MACD 0.38 0.24
Stochastic Oscillator 74.24 72.51

Price Performance

Historical Comparison
UGRO
PRFX

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: